Your browser doesn't support javascript.
loading
A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1/GSK-3ß pathway.
Yu, Xinwei; Xiao, Qiming; Yu, Xixi; Cheng, Yu; Lin, Hao; Xiang, Zheng.
Affiliation
  • Yu X; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
  • Xiao Q; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
  • Yu X; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
  • Cheng Y; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
  • Lin H; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
  • Xiang Z; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China; Medical School, Zhejiang University City College, Hangzhou, 310015, China. Electronic address: Xiangz@zucc.edu.cn.
J Ethnopharmacol ; 297: 115535, 2022 Oct 28.
Article in En | MEDLINE | ID: mdl-35840059
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphatidylinositol 3-Kinases / Kidney Diseases Type of study: Prognostic_studies Language: En Journal: J Ethnopharmacol Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphatidylinositol 3-Kinases / Kidney Diseases Type of study: Prognostic_studies Language: En Journal: J Ethnopharmacol Year: 2022 Type: Article Affiliation country: China